Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Click below to view purity certificates for every lot of this compound
Reporting suspected adverse reactions : If you experience a suspected side effect from an unlicensed product, please report it via the MHRA Yellow Card scheme (available at yellowcard.mhra.gov.uk)
It is in Phase 3 investigational trials as a "next generation" weight loss medication with potentially fewer side effects compared to single-receptor predecessors like Semaglutide or dual receptor meds like Tirzepatide
New chest pain, shortness of breath, one-sided leg swelling, or fainting should be treated as urgent symptoms
BPC-157 is a repair assist for joint pain, not a cure for arthritis
US$ 29.74
US$ 26.78
US$ 21.96
